摘要
目的探讨18F-FDG符合线路SPECT/CT检查诊断卵巢肿瘤治疗后复发及转移的价值。方法对40例临床疑有复发和转移的卵巢癌患者行18F-FDG符合线路SPECT/CT显像,并将结果与病理检查结果比较。结果病理检查证实36例均复发或转移。18F-FDG符合线路SPECT/CT显像检查29例阳性,血清CA125示22例升高,与病理检查结果比较,前者监测复发及转移的灵敏度、特异性和准确性分别为80.6%、100.0%、82.5%;后者为61.1%、100.0%、72.5%,二者灵敏度、准确性比较,P均<0.05。结论18F-FDG符合线路SPECT/CT显像监测卵巢癌复发和转移的灵敏度和特异性均优于CA125检测,可提高隐匿性复发或转移病灶的检出率。
Objective To investigate the diagnostic value of 18F-FDG coincidence SPECT/CT for the relapse and metastasis of ovarian cancer after treatment. Methods The 40 ovarian cancer cases of clinical suspected recurrence and metastasis were examined by 18F-FDG coincidence SPECT/CT and the results were compared with the pathological results. Results Thirty-six cases were confirmed recurrenceor metastasis by pathological method. 18F-FDG coincidence SPECT/CT imaging showed that 29 patients were positive,the serum CA125 of 22 patients increased. Compared with pathological results ,the sensitivity,specificity and accuracy of 18F-FDG coincidence SPECT /CT imaging were 80.6%,100.0% and 82.5%,which of CA125 were 61.1%,100.0% and 72.5%,and there were significant differences between their sensitivity and accuracy (P<0.05). Conclusions The sensitivity and specificity of 8F-FDG coincidence SPECT / CT imaging for monitoring recurrence and metastasis of ovarian cancer are superior to CA125 test,and it can improve detection rate of occult recurrence or metastasis.
出处
《山东医药》
CAS
北大核心
2009年第51期31-32,共2页
Shandong Medical Journal
